Clinical Trial

A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

Name: A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants — clinical trial record (NCT07681479)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-center, open-label, single-dose phase I clinical trial. The trial is divided into four periods: screening, baseline, treatment, and follow-up

Trial Details

NCT Number	NCT07681479
Lead Sponsor	Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions	Fluid Retention Due to Heart Failure
Enrollment	6 participants
Start Date	2026-07
Primary Completion	2026-07 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-02